The purpose of this multi-site study is to develop and evaluate a multi-phase implementation and sustainment strategy to support evidence-based practice use across different interventions for individuals with autism, settings, and ages.
*In partnership with UCLA, UC Davis, Rochester, Penn, Drexel, and Kansas
The aims of the current project are to: 1) Engage stakeholders to identify targets for ACT SMART redesign to optimize its fit for middle and high school providers who serve autistic adolescents; 2) Conduct prototyping and usability field testing of the redesigned ACT SMART and iteratively refine to ensure usability, feasibility, acceptability, and appropriateness for use in schools.
As rates of pediatric mental health emergencies have
skyrocketed over the last decade – and even more so since the Covid-19 pandemic
– the number of youth staying in emergency departments (EDs) and medical units
while awaiting inpatient psychiatric care or stabilization (i.e., “boarding”)
has reached unprecedented levels. The massive surges in patient volume, coupled
with widespread staff shortages and lack of staff expertise in treating mental
health, are overwhelming ED and hospital resources. This causes dangerous or
even life-threatening delays in care for youth populations in greatest need of
medical and psychiatric treatment. Prolonged ED stays not only delay necessary
mental health care, but they can cause additional trauma and distress for youth
already in crisis. While the boarding crisis affects all hospitals and EDs, it
poses an even greater challenge to community EDs that lack on-site mental
health specialists and/or pediatric providers.
To address the boarding crisis, this project will pilot a
model in which a multidisciplinary team of mental health clinicians at Seattle
Children’s Hospital provides telebehavioral health consultation to community
EDs in Western Washington to guide care for youth who are boarding. The primary
goals of this model are (1) to improve timeliness of mental health care and
reduce length of stay for youth boarding in community EDs, and (2) to support
ED staff in providing more developmentally appropriate and evidence-informed
mental healthcare. The Seattle Children’s team will provide case consultation
to ED providers and staff, including support with decisions about
hospitalization, medication treatment, behavioral interventions and case
management services. The team will also deliver practical trainings to
community ED staff to build their internal capacity to care for boarding youth.
If this initiative is successful, additional funding could expand ED
telebehavioral health consultation services statewide, with a focus on rural
communities.
The purpose of this study is to: 1) compare schools randomized to the RUBIES intervention or a usual-care in-service training on teacher burnout and disruptive behavior in children with autism spectrum disorder; and 2) test RUBIES’ mechanisms of change (knowledge and skills) on teacher (burnout), child (disruptive behavior), and implementation outcomes (fidelity).
The goal of this project is to engage more families of children with CHD8 mutations with a novel online platform (GroopIt) and to empower families to be partners in research. We are utilizing a community-based participatory research (CBPR) approach to enable families to identify research priorities. Through an established Facebook group for CHD8, families will be surveyed to prioritize research topics of interest that were identified in previous focus groups, such as parenting stress or gastrointestinal problems. The use of the updated GroopIt platform as an innovative, online tool will increase both the engagement and accessibility of research to families of children with rare genetic disorders associated with ASD.
The GENDAAR 2.0 study is part of the Autism Center of Excellence (ACE Network), which includes researchers from across the country. The main goal of this follow up study is to investigate the transition through adolescence and into young adulthood. We aim to identify sex differences in individuals with autism spectrum disorders (ASD) and look at their brain development during this important transition. We will compare the data collected with individuals with ASD, to siblings of children with ASD and children with no family history of ASD. We will use a variety of methods: neuropsychological testing, EEG, fMRI, and genetics. By learning more about sex differences, we aim to improve techniques for diagnosis and interventions.
To evaluate the efficacy of ZYN002 administered as a transdermal gel formulation, for up to 12 weeks, in patients ages 3 to <18 years, in the treatment of symptoms of Fragile X Syndrome (FXS).